BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
121 hedge funds and large institutions have $933M invested in BELLUS Health Inc. in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 16 closing their positions.
216% more call options, than puts
Call options by funds: $693K | Put options by funds: $219K
33% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 36
31% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 16
4% more funds holding
Funds holding: 116 → 121 (+5)
12% less capital invested
Capital invested by funds: $1.06B → $933M (-$131M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCOC
Power Corp of Canada
Montreal, Quebec,
Canada
|
+$46M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$15.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.95M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$9.75M |
| 5 |
Goldman Sachs
New York
|
+$8.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$21.4M |
| 2 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$15.6M |
| 3 |
PA
Perceptive Advisors
New York
|
-$12.6M |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$12M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$8.45M |
BLU Hedge Fund Activity: Q4 2022 in Review
121 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2022, worth a combined $933M — down 12% from $1.06B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new BLU positions and 16 closed out — a net gain of 5 holders — while 48 added to existing stakes and 36 trimmed.
The largest buyer was Power Corp of Canada, opening a new position worth an estimated $46M. The largest seller was Artal Group, cutting an estimated $21.4M.
- 121 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2022, up from 116 in Q3 2022.
- Funds reported $933M of BELLUS Health Inc. stock for Q4 2022, down 12% quarter-over-quarter.
- 21 funds opened new BELLUS Health Inc. positions in Q4 2022 and 16 closed out, a net change of +5 holders.
- The largest BELLUS Health Inc. buyer in Q4 2022 was Power Corp of Canada, an estimated $46M added.
- The largest BELLUS Health Inc. seller in Q4 2022 was Artal Group, an estimated $21.4M sold.
Based on aggregated 13F filings for Q4 2022.